We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Edge Therapeutics, Inc. | NASDAQ:EDGE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.5036 | 0.50 | 0.53 | 0 | 01:00:00 |
Delaware
|
001-37568
|
26-4231384
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Recipient
|
Title
|
Options with a Grant
Date of June 19, 2018
|
RSUs with a Grant
Date of August 14,
2018
|
Brian A. Leuthner
|
President and Chief Executive Officer
|
338,068
|
169,032
|
Andrew Saik
|
Chief Financial Officer
|
166,001
|
82,999
|
Herbert J. Faleck
|
Chief Medical Officer
|
119,667
|
59,833
|
Dated: June 20, 2018
|
Edge Therapeutics, Inc.
|
|
|
|
|
|
By:
|
/s/ W. Bradford Middlekauff
|
|
|
Name: W. Bradford Middlekauff
|
|
|
Title: Senior Vice President, General Counsel and Secretary
|
1 Year EDGE THERAPEUTICS, INC. Chart |
1 Month EDGE THERAPEUTICS, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions